Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

PDGF and its receptors are crucial for stem cell growth and function.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

The Fas/FasL pathway may play a role in alopecia areata.

Muscarinic acetylcholine receptors in skin cells help regulate and promote hair growth.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

FFA has higher long-term remission rates than LPP.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Mouse touch-sensitive nerve cells adjust their connections based on competition with other similar cells.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

JAK inhibitors might help treat Lichen Planopilaris, but more research is needed.

Lichen planopilaris may have a genetic link.

Combining PDLLA and PRP effectively reduces wrinkles and improves skin quality.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Activating TRPA1 reduces scarring and promotes tissue regeneration.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Leptin may play a role in hair growth and hair follicle health.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Long-lived proteins may predict age-related diseases.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.